Reviewing the Landscape of Psychopharmacology
A special issue of Life (ISSN 2075-1729). This special issue belongs to the section "Pharmaceutical Science".
Deadline for manuscript submissions: closed (28 April 2026) | Viewed by 4365
Special Issue Editor
Interests: psychopharmacology; mood and anxiety disorders; neurobiology of psychiatric treatments; clinical and translational research; drug safety in adult populations
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Psychopharmacology remains a rapidly evolving field, existing at the intersection of neuroscience, psychiatry, and pharmacology. Over recent decades, advances in neurobiology and neuroimaging have deepened our understanding of the mechanisms underlying psychiatric disorders and their pharmacological treatments. At the same time, new challenges have emerged, including the need to improve the safety profiles of existing psychotropic medications, to address off-label prescribing practices, and to develop more personalized and mechanistically informed therapeutic strategies.
This Special Issue aims to provide a comprehensive and critical overview of current trends, controversies, and innovations in psychopharmacology. We welcome contributions that explore the efficacy, safety, and mechanisms of action of psychotropic drugs, including antidepressants, mood stabilizers, antipsychotics, anxiolytics, and stimulants. Potential submissions may include narrative or systematic reviews, meta-analyses, conceptual papers, or original data-driven contributions with a strong translational or clinical focus.
Topics of interest include, but are not limited to, the following areas: the neurobiological underpinnings of drug action; real-world data on safety and tolerability; psychopharmacological interventions in mood and anxiety disorders; pharmacovigilance and long-term outcomes; and ethical or regulatory issues surrounding novel therapeutics. We also encourage submissions addressing underexplored populations, such as adults with neurodevelopmental conditions or those with psychiatric comorbidities.
By bringing together diverse perspectives and methodologies, this Special Issue seeks to map the evolving landscape of psychopharmacology and to highlight future directions for both research and clinical practice.
Prof. Dr. Luca Steardo
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Life is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- psychopharmacology
- mood disorders
- neurobiology
- drug safety
- translational psychiatry
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
